Bicocca Open Archive

Logo unimib boa
BOMBELLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.259
AS - Asia 7.612
EU - Europa 6.643
SA - Sud America 1.134
AF - Africa 119
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 10
Totale 28.792
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.937
SG - Singapore 3.248
CN - Cina 1.838
HK - Hong Kong 1.251
IT - Italia 1.236
RU - Federazione Russa 1.225
DE - Germania 1.133
BR - Brasile 907
SE - Svezia 858
IE - Irlanda 706
VN - Vietnam 523
UA - Ucraina 442
GB - Regno Unito 353
CA - Canada 223
FI - Finlandia 174
IN - India 165
FR - Francia 128
KR - Corea 128
AR - Argentina 102
ID - Indonesia 75
NL - Olanda 75
BD - Bangladesh 69
MX - Messico 64
ZA - Sudafrica 62
AT - Austria 56
TR - Turchia 56
DK - Danimarca 49
PL - Polonia 49
JP - Giappone 46
EC - Ecuador 45
IQ - Iraq 38
ES - Italia 34
UZ - Uzbekistan 23
CZ - Repubblica Ceca 22
CO - Colombia 21
BE - Belgio 20
IR - Iran 17
PK - Pakistan 16
KE - Kenya 15
RO - Romania 15
CL - Cile 14
AE - Emirati Arabi Uniti 13
SA - Arabia Saudita 13
VE - Venezuela 13
PY - Paraguay 12
EU - Europa 11
MA - Marocco 11
PE - Perù 11
LT - Lituania 10
MY - Malesia 10
AZ - Azerbaigian 9
CH - Svizzera 9
PA - Panama 9
AU - Australia 8
PH - Filippine 7
TW - Taiwan 7
JO - Giordania 6
KH - Cambogia 6
LK - Sri Lanka 6
PT - Portogallo 6
TH - Thailandia 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
KZ - Kazakistan 5
LV - Lettonia 5
UY - Uruguay 5
AL - Albania 4
BB - Barbados 4
BH - Bahrain 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
LB - Libano 4
NP - Nepal 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BJ - Benin 3
BO - Bolivia 3
BY - Bielorussia 3
EE - Estonia 3
LA - Repubblica Popolare Democratica del Laos 3
PS - Palestinian Territory 3
XK - ???statistics.table.value.countryCode.XK??? 3
CM - Camerun 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
OM - Oman 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 28.777
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.953
Singapore 1.718
Hong Kong 1.247
Ashburn 1.167
Woodbridge 944
Fairfield 824
Houston 777
Chandler 708
Frankfurt am Main 699
Dublin 668
Wilmington 489
Jacksonville 466
New York 439
Dearborn 435
Seattle 377
Milan 373
Beijing 343
Santa Clara 322
Hefei 294
Cambridge 268
Princeton 244
Dallas 231
Los Angeles 203
Ho Chi Minh City 131
Hanoi 130
Nanjing 130
Seoul 123
Altamura 122
Moscow 122
Lawrence 117
Shanghai 116
Chicago 108
Buffalo 92
Munich 90
The Dalles 83
São Paulo 82
Lachine 79
San Diego 77
Guangzhou 59
Nanchang 52
Helsinki 51
Jakarta 47
Boardman 46
London 46
Toronto 44
Andover 43
Council Bluffs 42
Warsaw 42
Rome 39
Dong Ket 38
Fremont 38
Tianjin 38
Tokyo 37
Hebei 36
Rio de Janeiro 35
Brooklyn 34
Shenyang 34
Salt Lake City 33
Vienna 32
Falls Church 31
Lissone 31
Montreal 31
Denver 30
Johannesburg 29
Turku 29
Atlanta 28
Nuremberg 28
Changsha 27
Chennai 27
Orem 27
Monza 25
Phoenix 25
Ottawa 24
Stockholm 23
Haiphong 22
Jiaxing 22
Amsterdam 21
Jinan 21
Kunming 21
Ningbo 21
Columbus 20
Manchester 20
Nürnberg 20
Tashkent 20
Da Nang 19
Poplar 19
San Jose 19
Zhengzhou 19
Brno 18
Norwalk 18
Porto Alegre 17
Brussels 16
New Delhi 16
Guayaquil 15
Mumbai 15
Belo Horizonte 14
Dhaka 14
Düsseldorf 14
Elk Grove Village 14
Hangzhou 14
Totale 18.541
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 393
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 371
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 319
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 314
Differing associations for sport versus occupational physical activity and cardiovascular risk 302
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 297
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 287
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 270
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 270
The Pamela study: main findings and perspectives 266
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 265
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 262
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 261
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 255
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 255
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 253
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 251
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 250
HYPERTENSIVE EMERGENCIES AND URGENCIES: ADHERENCE TO GUIDELIENS AND RELATIONSHIP BETWEEN BLOOD PRESSURE MANAGEMENT AND IN-HOSPITAL MORTALITY 248
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 246
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 239
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 238
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 238
Combined effects of hypertension and hypercholesterolemia on radial artery function 234
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 234
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 229
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 228
The association between 24-h blood pressure patterns and left ventricular mechanics 228
Role of ambulatory blood pressure monitoring in resistant hypertension 226
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 225
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 223
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 223
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 222
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 221
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 219
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 218
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 218
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 217
New-onset left atrial enlargement in a general population 217
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 216
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 215
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 214
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 213
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 213
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 213
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 212
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 209
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 208
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 207
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 207
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 205
Diurnal blood pressure variation and sympathetic activity 204
Should white-coat hypertension in diabetes be treated? Pro 200
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 200
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 199
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 199
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 198
HIV and metabolic syndrome - A comparison with the general population 197
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 197
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 197
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 196
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 194
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 194
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 191
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 191
The Pamela Study: Old and New Findings 189
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 188
Importance of uric acid threshold in its correlation with metabolic syndrome 188
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 187
Diagnosis and management of patients with white-coat and masked hypertension 186
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 186
Predictive value of different indices of blood pressure variability on 186
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 185
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 183
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 183
Neurological hypertensive emergencies: Correlation of blood pressure values with in-hospital outcomes in ischemic stroke 180
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 180
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 180
Long-term risk of sustained hypertension in white-coat or masked hypertension 177
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 176
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 174
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 174
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 174
Metabolic Syndrome is Related to Vascular Structural Alterations But Not to Functional one both in Hypertensives and Healthy Subjects in Selected abstracts from the XXXVIII National Congress of the Italian Society of Hypertension (SIIA) 173
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 173
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 172
Resting Heart Rate and Arterial Stiffness: a Longitudinal Prospective Study in a Population of Hypertensive Patients 171
Incidence and risk factors for delayed intracranial hemorrhage after mild brain injury in anticoagulated patients: a multicenter retrospective study 170
Ambulatory blood pressure in air traffic controllers 170
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 170
Do reverse dippers have the highest risk of right ventricular remodeling? 170
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 166
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 165
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 165
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 160
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 159
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial) 158
Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension 157
Williams syndrome is associated with an increase in heart rate and wave reflection values during the nighttime period. 157
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 155
Totale 21.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.411 0 0 0 0 0 203 219 225 185 262 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/20256.152 319 718 285 281 476 170 269 274 570 858 737 1.195
2025/20267.040 1.463 858 1.083 1.505 1.539 592 0 0 0 0 0 0
Totale 29.435